Weight medication: has your insurance coverage changed?

A notice from your benefits plan can change the cost of care overnight. Before booking another appointment or making a treatment change, find out what the notice actually means: has coverage ended, is prior authorization needed, or is information missing? Each calls for a different next step.

If coverage changes, ask your insurer for the exact reason, then discuss your care plan with your clinician before making treatment changes. (Read more)

A current example applies to one specific plan

In a notice for CAEAS-ECAB members, ONE-T announced that coverage for anti-obesity drugs would end on September 1, 2026. The notice treats certain GLP-1 uses for other medical conditions separately, subject to prior authorization. This change applies to the plan described in that notice. It does not establish a change to your own insurance or a blanket rule in Ontario or Quebec. Source: ONE-T.

1. Get the exact reason for the coverage problem

Ask your insurer to identify the product, effective date and written reason: is it excluded from your plan, awaiting prior authorization, or missing information? Also ask whether an existing authorization remains valid. Canada Life offers a drug search linked to your plan; a pharmacy may also receive a message when prior authorization is required. Keep the insurer’s answer for your next conversation. Sources: Canada Life.

2. Prescribing and reimbursement are separate decisions

Your clinician assesses treatment; your insurer assesses coverage under your plan. Canada Life explains that some medications need prior authorization before reimbursement is considered. Ask your insurer what information is required and where your request stands. If it is declined, check the appeal process for your plan. A prescription does not establish insurer approval, and this guide cannot determine your eligibility. Sources: Canada Life and MedVibe.

3. Bring the practical details to your care team

If the cost is becoming hard to sustain, tell your prescriber or pharmacist before your supply runs out. Have the notice, product name, remaining supply and questions ready. Canadian guidance includes personal preferences, health goals and affordability in treatment decisions. ONE-T’s notice also directs affected members to their physician or pharmacist to discuss options. Sources: Obesity Canada and ONE-T.

4. Price alone cannot choose a treatment

Changing the dose, timing or product calls for professional advice tailored to your circumstances. Health Canada says prescription medicines require professional supervision and advises against unauthorized GLP-1 products. Canadian clinical guidance supports individualized care. A lower-priced social-media offer is not a substitute for those checks. Sources: Health Canada and Obesity Canada.

5. When a MedVibe assessment may fit

Start with your insurer if your only question is reimbursement. If you want to discuss care options with a clinician, eligible adults in Ontario and Quebec can request MedVibe’s weight-management assessment. The clinician reviews the context and decides on next steps; in-person care may be more appropriate. The consultation, medication and any third-party costs are separate. Paying for an assessment does not determine the prescription or the insurer’s decision. Source: MedVibe.

This guide helps you prepare a conversation; it does not change your treatment or interpret your benefits contract. If an interruption is approaching, you have side effects or new symptoms, contact your care team without waiting for an administrative answer. Prescriptions, renewals, forms and outcomes remain subject to assessment.